Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125278621 | 12527862 | 1 | I | 2012 | 20160623 | 20160705 | 20160705 | EXP | US-BAYER-2016-124921 | BAYER | 0.00 | M | Y | 0.00000 | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125278621 | 12527862 | 1 | PS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 103471 | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | ||||||||||
| 125278621 | 12527862 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 0000078236 | 0 | 10 | MG | TABLET | BID | |||||
| 125278621 | 12527862 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, QD | 0000078236 | 0 | 10 | MG | TABLET | QD | |||||
| 125278621 | 12527862 | 4 | SS | NOVANTRONE | MITOXANTRONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 125278621 | 12527862 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 125278621 | 12527862 | 6 | SS | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | UNK | 0 | ||||||||||
| 125278621 | 12527862 | 7 | C | ATENOLOL. | ATENOLOL | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 125278621 | 12527862 | 8 | C | ALEMTUZUMAB | ALEMTUZUMAB | 1 | UNK | 0 | |||||||||||
| 125278621 | 12527862 | 9 | C | VALSARTAN. | VALSARTAN | 1 | 320 MG, UNK | 0 | 320 | MG | |||||||||
| 125278621 | 12527862 | 10 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 20 MG, UNK | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125278621 | 12527862 | 1 | Multiple sclerosis |
| 125278621 | 12527862 | 2 | Gait disturbance |
| 125278621 | 12527862 | 3 | Gait disturbance |
| 125278621 | 12527862 | 4 | Multiple sclerosis |
| 125278621 | 12527862 | 5 | Multiple sclerosis |
| 125278621 | 12527862 | 6 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125278621 | 12527862 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125278621 | 12527862 | Adverse event | |
| 125278621 | 12527862 | Arthralgia | |
| 125278621 | 12527862 | Band sensation | |
| 125278621 | 12527862 | Chest pain | |
| 125278621 | 12527862 | Coordination abnormal | |
| 125278621 | 12527862 | Dyspnoea | |
| 125278621 | 12527862 | Full blood count decreased | |
| 125278621 | 12527862 | Gait disturbance | |
| 125278621 | 12527862 | Mobility decreased | |
| 125278621 | 12527862 | Movement disorder | |
| 125278621 | 12527862 | Musculoskeletal disorder | |
| 125278621 | 12527862 | Peroneal nerve palsy | |
| 125278621 | 12527862 | Therapeutic product ineffective | |
| 125278621 | 12527862 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125278621 | 12527862 | 2 | 2010 | 0 | ||
| 125278621 | 12527862 | 3 | 20160321 | 20160402 | 0 | |
| 125278621 | 12527862 | 4 | 2014 | 0 | ||
| 125278621 | 12527862 | 6 | 20150915 | 0 | ||
| 125278621 | 12527862 | 8 | 20151207 | 0 |